Randomized double blind trial of amitriptyline versus placebo in treatment of chronic laryngopharyngeal neuropathy

A neuropathic etiology has been suggested for patients with chronic laryngopharyngitis symptoms without visible structural pathology. Prior studies have shown that treatment with neuro-modulating medications is beneficial, but it is unknown if this was due to placebo effect. Our objective was to compare the efficacy of amitriptyline versus placebo in treating chronic laryngopharyngeal neuropathy.

http://ift.tt/2tgPgzM